Background: Tachycardia and hypertension are well documented sequels of laryngoscopy and endotracheal intubation; they are transient, highly variable and are generally well tolerated in healthy patients. In hypertensive patients with coronary artery disease (CAD) these cardiovascular responses to laryngoscopy and intubation is exaggerated. The aim of this study was to evaluate the efficacy of lidocaine in attenuating cardiovascular response to laryngoscopy and endotracheal intubation in patients posted for elective off pump coronary artery bypass grafting (OPCABG) as these patients are on a low dose of ß-blockers. Materials and Methods: After obtaining institutional ethical approval, 60 patients aged 40 to 70 years from either sex of the American Society of Anaesthesiologists (ASA) physical status III with coronary artery disease (CAD) undergoing elective coronary artery bypass grafting (CABG) surgery under general anaesthesia were selected for the study. Participants were randomly allocated into two groups comprising 30 subjects each. Group I received lidocaine 1.5 mg/kg and group II (control) received a placebo (normal saline) 3 minutes prior to laryngoscopy. Changes in heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and rate pressure product (RPP) were measured before induction as baseline, after intubation, at minute 1, 3, 5 and 7 minutes respectively after tracheal intubation while they were also observed for any complications. Results: There was a significant increase in HR, SBP, DBP, MAP and RPP in the control (placebo) group as compared to the lidocaine group (P < 0.05) at 1 minute with onward decreases at 3, 5, and 7 minutes respectively after intubation. Conclusions: Prophylactic therapy with lidocaine was found to be safe and effective in attenuating cardiovascular responses to laryngoscopy and tracheal intubation in patients posted for elective OPCABG on a low dose of ß-blockers.
Published in | Journal of Anesthesiology (Volume 1, Issue 3) |
DOI | 10.11648/j.ja.20130103.13 |
Page(s) | 27-35 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2013. Published by Science Publishing Group |
Blood Pressure, Heart Rate, Intubation, Laryngoscopy, Lidocaine (Source: Mesh, NLM)
[1] | Singh S, Laing EF, Owiredu WKBA, Singh A. Attenuation of Cardiovascular response by ß-blocker esmolol during laryngoscopy and intubation. Journal of Medical and Biomedical Sciences (UDS).2012; 4: 27-33. |
[2] | Ishikawa T, Nishino T, Hiraga K. Immediate response to arterial blood pressure and heart rate to sudden inhalation of high concentration of isoflurane in normotensive and hypertensive patients. Anesth Analg.1993; 77: 1022-5. |
[3] | Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology.1985; 62: 107-114. |
[4] | Tian-long W, Yan J, Ba-xian Y. Effect of nicardipine combined with esmolol on systemic and tissue oxygenation during off-pump coronary artery bypass grafting surgery.Chin Med J.2005;118:130-5. |
[5] | Takita K, Morimoto Y, Kemmotsu O. Tracheal lidocaine attenuates the cardiovascular response to endotracheal intubation. Can J Anaesth 2001; 48: 732-6. |
[6] | Begum M, Akter P, Hossain MM, Alim SMA, Khatun UHS, Islam SMK. A comparative study between efficacy of esmolol and lignocaine for attenuating haemodynamics response due to laryngoscopy and endotracheal intubation. Faridpur Medical College Journal.2010; 5: 25-28. |
[7] | Miller CD, Warren SJ. Intravenous lignocaine fails to attenuate the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth.1990; 65: 216‑9. |
[8] | Gonzalez P, Cuccurullo S, Jafri I, Luciano L. Cardiac Rehabilitation. Physical Medicine and Rehabilitation Board Review.2004; Bookshelf ID: NBK27286. |
[9] | Savio KH, Tait G, Karkouti K, Wijeysundera D, McCluskey S, Beattie WS. The Safety of Perioperative Esmolol: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Anesthesia & analgesia.2011; 112: 267-281. |
[10] | Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative Myocardial Infarction. Circulation.2009; 119: 2936-44. |
[11] | Sener EB, Ustun E, Ustun B, Sarihasan B. Hemodynamic responses and upper airway morbidity following tracheal intubation in patients with hypertension: Conventional laryngoscopy versus an intubating laryngeal mask airway. Clinics.2012; 67: 49-54. |
[12] | Manjunath HG, Venkatesh GS, Prima V, Jennifer LV, Sathees BC. Can calcium and sodium channel blockers attenuate hemodynamic responses to endotracheal intubation? Eur J Gen Med.2008; 5: 198‑207. |
[13] | Tam S, Chung F, Campbell M. Intravenous lidocaine: optimal time of injection before tracheal intubation. Anesth Analg.1987; 66: l036-8. |
[14] | Wilson IG, Meiklejohn BH, Smith G.Intravenous lignocaine and sympathoadrenal responses to laryngoscopy and intubation. The effect of varying time of injection. Anaesthesia.1991; 46: 177–80. |
[15] | Mollick MT, Hossain MD, Ali NP. Attenuation of cardiovascular response during laryngoscopy and endotracheal intubation by using pethidine with lignocaine. JAFMC Bangladesh.2010; 6: 40–43. |
[16] | Abou-Madi MN, Keszler H, Yacoub JM. Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine. Can Anaesth Soc J.1977; 24: 12-9. |
[17] | Lev R, Rosen P. Prophylactic lidocaine use preintubation: a review. J Emerg Med. 1994; 12: 499-506. |
APA Style
S. Singh, Kulsum, H. Shroff, A. Singh, A. Annamalai, et al. (2013). Can Sodium Channel Blocker Lidocaine Attenuate Haemodynamic Responses to Endotracheal Intubation in Patients with Coronary Artery Disease Effectively. International Journal of Anesthesia and Clinical Medicine, 1(3), 27-35. https://doi.org/10.11648/j.ja.20130103.13
ACS Style
S. Singh; Kulsum; H. Shroff; A. Singh; A. Annamalai, et al. Can Sodium Channel Blocker Lidocaine Attenuate Haemodynamic Responses to Endotracheal Intubation in Patients with Coronary Artery Disease Effectively. Int. J. Anesth. Clin. Med. 2013, 1(3), 27-35. doi: 10.11648/j.ja.20130103.13
AMA Style
S. Singh, Kulsum, H. Shroff, A. Singh, A. Annamalai, et al. Can Sodium Channel Blocker Lidocaine Attenuate Haemodynamic Responses to Endotracheal Intubation in Patients with Coronary Artery Disease Effectively. Int J Anesth Clin Med. 2013;1(3):27-35. doi: 10.11648/j.ja.20130103.13
@article{10.11648/j.ja.20130103.13, author = {S. Singh and Kulsum and H. Shroff and A. Singh and A. Annamalai and D. E. Mahrous}, title = {Can Sodium Channel Blocker Lidocaine Attenuate Haemodynamic Responses to Endotracheal Intubation in Patients with Coronary Artery Disease Effectively}, journal = {International Journal of Anesthesia and Clinical Medicine}, volume = {1}, number = {3}, pages = {27-35}, doi = {10.11648/j.ja.20130103.13}, url = {https://doi.org/10.11648/j.ja.20130103.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ja.20130103.13}, abstract = {Background: Tachycardia and hypertension are well documented sequels of laryngoscopy and endotracheal intubation; they are transient, highly variable and are generally well tolerated in healthy patients. In hypertensive patients with coronary artery disease (CAD) these cardiovascular responses to laryngoscopy and intubation is exaggerated. The aim of this study was to evaluate the efficacy of lidocaine in attenuating cardiovascular response to laryngoscopy and endotracheal intubation in patients posted for elective off pump coronary artery bypass grafting (OPCABG) as these patients are on a low dose of ß-blockers. Materials and Methods: After obtaining institutional ethical approval, 60 patients aged 40 to 70 years from either sex of the American Society of Anaesthesiologists (ASA) physical status III with coronary artery disease (CAD) undergoing elective coronary artery bypass grafting (CABG) surgery under general anaesthesia were selected for the study. Participants were randomly allocated into two groups comprising 30 subjects each. Group I received lidocaine 1.5 mg/kg and group II (control) received a placebo (normal saline) 3 minutes prior to laryngoscopy. Changes in heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and rate pressure product (RPP) were measured before induction as baseline, after intubation, at minute 1, 3, 5 and 7 minutes respectively after tracheal intubation while they were also observed for any complications. Results: There was a significant increase in HR, SBP, DBP, MAP and RPP in the control (placebo) group as compared to the lidocaine group (P < 0.05) at 1 minute with onward decreases at 3, 5, and 7 minutes respectively after intubation. Conclusions: Prophylactic therapy with lidocaine was found to be safe and effective in attenuating cardiovascular responses to laryngoscopy and tracheal intubation in patients posted for elective OPCABG on a low dose of ß-blockers.}, year = {2013} }
TY - JOUR T1 - Can Sodium Channel Blocker Lidocaine Attenuate Haemodynamic Responses to Endotracheal Intubation in Patients with Coronary Artery Disease Effectively AU - S. Singh AU - Kulsum AU - H. Shroff AU - A. Singh AU - A. Annamalai AU - D. E. Mahrous Y1 - 2013/12/20 PY - 2013 N1 - https://doi.org/10.11648/j.ja.20130103.13 DO - 10.11648/j.ja.20130103.13 T2 - International Journal of Anesthesia and Clinical Medicine JF - International Journal of Anesthesia and Clinical Medicine JO - International Journal of Anesthesia and Clinical Medicine SP - 27 EP - 35 PB - Science Publishing Group SN - 2997-2698 UR - https://doi.org/10.11648/j.ja.20130103.13 AB - Background: Tachycardia and hypertension are well documented sequels of laryngoscopy and endotracheal intubation; they are transient, highly variable and are generally well tolerated in healthy patients. In hypertensive patients with coronary artery disease (CAD) these cardiovascular responses to laryngoscopy and intubation is exaggerated. The aim of this study was to evaluate the efficacy of lidocaine in attenuating cardiovascular response to laryngoscopy and endotracheal intubation in patients posted for elective off pump coronary artery bypass grafting (OPCABG) as these patients are on a low dose of ß-blockers. Materials and Methods: After obtaining institutional ethical approval, 60 patients aged 40 to 70 years from either sex of the American Society of Anaesthesiologists (ASA) physical status III with coronary artery disease (CAD) undergoing elective coronary artery bypass grafting (CABG) surgery under general anaesthesia were selected for the study. Participants were randomly allocated into two groups comprising 30 subjects each. Group I received lidocaine 1.5 mg/kg and group II (control) received a placebo (normal saline) 3 minutes prior to laryngoscopy. Changes in heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and rate pressure product (RPP) were measured before induction as baseline, after intubation, at minute 1, 3, 5 and 7 minutes respectively after tracheal intubation while they were also observed for any complications. Results: There was a significant increase in HR, SBP, DBP, MAP and RPP in the control (placebo) group as compared to the lidocaine group (P < 0.05) at 1 minute with onward decreases at 3, 5, and 7 minutes respectively after intubation. Conclusions: Prophylactic therapy with lidocaine was found to be safe and effective in attenuating cardiovascular responses to laryngoscopy and tracheal intubation in patients posted for elective OPCABG on a low dose of ß-blockers. VL - 1 IS - 3 ER -